SRL
RYTM icon

Scientech Research LLC’s Rhythm Pharmaceuticals RYTM Stock Holding History

Scientech Research LLC’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,125
Closed -$235K – 556
2023
Q4 		$235K Buy
+5,125
New +$162K 0.23% 195

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Scientech Research LLC's RYTM Position: Q1 2024 in Review

Scientech Research LLC sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2024, closing a stake of 5,125 shares — an estimated $235K sold.

Scientech Research LLC first reported a position in RYTM in Q4 2023 and held it in 1 quarter. The position peaked at $235K in Q4 2023. 167 funds tracked by Wall St. Rank hold RYTM as of Q1 2024.

  • Scientech Research LLC reported no remaining Rhythm Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Scientech Research LLC sold 5,125 Rhythm Pharmaceuticals shares in Q1 2024, an estimated $235K.
  • Scientech Research LLC first reported a position in Rhythm Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Scientech Research LLC's Rhythm Pharmaceuticals position peaked at $235K in Q4 2023.
  • 167 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2024.

Based on Scientech Research LLC's 13F filing for Q1 2024, filed 15 May 2024.